Showing results (491-500 of 835) with videos related to
Sort By:
Pageof 84
Current Oncology (Toronto, Ont.)|June 25, 2025
Beyond Barriers: Achieving True Equity in Cancer CareZaphrirah S Chin, Arshia Ghodrati, Milind Foulger, et al.Journal of Medicinal Chemistry|September 10, 1999
Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluationG H Posner, Q Wang, G Han, et al.Archives of Neurology|March 20, 2001
An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer diseaseY Stern, D Jacobs, J Goldman, et al.Journal of Cellular Biochemistry|October 4, 2005
Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastomaC Damodar Reddy, Ratnakar Patti, Asha Guttapalli, et al.Annals of Neurology|June 1, 1997
Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13?K Wilhelmsen, D Mirel, K Marder, et al.Journal of Neuro-Aids|January 1, 1996
Gender Differences in HIV-Related Neurological Progression in a Cohort of Injecting Drug Users Followed for 3.5 YearsX Liu, K Marder, Y Stern, et al.Neurology|April 24, 2002
Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutationsK Hedrich, K Marder, J Harris, et al.Bioorganic & Medicinal Chemistry|September 13, 2001
A non-calcemic sulfone version of the vitamin D(3) analogue seocalcitol (EB 1089): chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycinG H Posner, K R Crawford, S Peleg, et al.Journal of Medicinal Chemistry|December 24, 2004
Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3)Mehmet Kahraman, Sandra Sinishtaj, Patrick M Dolan, et al.Neurology|July 9, 2003
Accuracy of family history data on Parkinson's diseaseK Marder, G Levy, E D Louis, et al.Pageof 84